Nonprofit

Pandemic Puts a Pause on Private Equity

Pandemic Puts a Pause on Private Equity
clock
3 min 36 sec

Posted by

This blog post from Callan’s Private Equity Consulting Group provides a high-level summary of private equity activity through all the investment stages, from fundraising to exits, as well as performance data across a range of market cycles. (Investment-stage data provided by PitchBook; performance data from Refinitiv/Cambridge.)

Fundraising: It’s Another Story Now

  • Fundraising took a steep drop in the first quarter, amid volatile public markets. Funds closing fell 39% from the prior quarter, while commitments were down 37%.
  • Fundraising is expected to continue to slow in 2020 due to delays caused by slower deployment rates of existing funds.
  • The “denominator effect” of institutional investors becoming over-allocated to private equity due to declines in total portfolio values has not—so far—been a significant influence.
  • Buyout funds fell to 44% of commitments, compared to 55% in 2019.
  • Venture capital started strong with a 25% commitment share, up from 11% for last year.
  • Mezzanine and distressed funds had a particularly weak quarter.
  • Energy, fund-of-funds, and secondary funds stayed steady at their long-term averages.
  • In the first quarter, U.S./North American funds received 74% of global commitments, with Europe at 13%, Asia at 11%, and other regions at 2%.
Funds Holding Final Closes: By Strategy

Buyout Investments: Price Discovery and Cautious Lenders

  • Buyouts declined notably, albeit from relatively high levels as general partners are focusing more on existing portfolio company health and less on starting new company platforms.
  • Lack of visibility on the future levels and timing of revenue and earnings has created significant price uncertainty, so most sellers and buyer are not finding mutual ground.
  • Transactions fell 20% from the prior quarter and dollar volume plunged 44%.
  • While public equity markets have rebounded after their peak-to-trough declines of about 30%, it is still too early to have clarity on the overall economic toll that will result from social-distancing protocols.

Prices Inch Down but Stay High

  • First quarter prices softened marginally. Average buyout prices were 11.2x EBITDA, down slightly from 11.4x EBITDA in 2019.
  • The transactions that closed in 1Q were largely deals-in-process prior to when the COVID-19 shutdowns began.
  • While prices fell, general partners put in more equity; the average contribution hit 5.9x, up 0.3x. Debt declined by 0.6x with the average stack in the 5.3x range.

Venture Capital Investments: Less Reactive

  • Venture capital (VC) investments also dropped, but not as steeply as buyouts. The number of rounds of financings in the first quarter dropped by 16% while announced dollars fell only 2%.
  • Large transactions still dominate with 32 financings of unicorns (VC companies with valuations of over $1 billion) in the first quarter totaling $16 billion.
  • Median venture prices for Series A through C continued to increase, but the median late-stage Series D round fell by 20%—the first decline since 2016.
  • Information Technology and Consumer Products and Services were the top categories by sector, with Health Care a close third.

Private Equity-Backed M&A Exits: Rapid Deceleration

  • Similar to investment activity, closed deals were largely those in process prior to the market downturn.
  • Exit count fell by 19% and announced value plunged 69%.

Private Equity-Backed M&A IPOs: Window Open for Just Six Weeks

  • Only 11 private equity-backed IPOs occurred in the first quarter, off 67% from 33 in the fourth quarter.
  • The total float fell only 14% to $6 billion.

Venture-Backed M&A Exits: OK for Now

  • Similar to new venture capital investments, the exits count dipped, but announced dollar volume remained healthy.
  • Venture-backed M&A exits by count were down 12%, with no change in announced value.

Venture-Backed IPOs: Limited Time Offer

  • Volume suffered from the short 1Q window of stable pricing. While public markets have recovered, confidence in smaller, newer companies will likely be low in the next several quarters.
  • The number of venture-backed IPO exits slowed in the first quarter, off by 34%, but the combined new issuance was down only 14% from the prior quarter.
Pooled horizon IRRs: By Strategy

Returns: Public Equity Jumps, but PE Still Outperforms in Long Term

  • U.S. public markets rocketed up in the fourth quarter, producing a one-year return in excess of 31%. Private equity’s gain was about half of public equity for the quarter and year.
  • On a public market equivalent (PME) basis, for all horizons past one year, the Refinitiv/Cambridge private equity database matched or outperformed broad public equity indices.
  • Volatility has been growing in recent years and public and private equity have been playing cat and mouse for near-term periods. While private equity tends to lag steep upward public stock returns, it has been very beneficial in drawdown periods—arguably when support is needed most.
  • Even with a moderate fourth quarter, private equity maintains consistent double-digit internal rates of return (IRR) across all the standard investment horizons of one year or longer, and has been competitive with public equity through the public market’s remarkable 10-year rise.

Posted by

Share
Share on facebook
Share on twitter
Share on linkedin
Related Posts
Private Markets

2024 Private Equity Fees and Terms Study: Lessons for Institutional Investors

Ashley Kahn
This study analyzes private equity fees and terms to help institutional investors.
Private Markets

Nonprofits: Same Mission, but New Approach to Allocations

Tony Lissuzzo
Callan expert discusses changes in nonprofit allocation trends over the last 20 years.
Private Markets

Some Early Signs of a Rebound, but Challenges Remain

Ashley Kahn
Callan expert analyzes private equity activity in 2Q24, from fundraising to exits.
Operations

A Deeper Look at How We Did With Our Capital Markets Assumptions

Julia Moriarty
An analysis of how Callan's Capital Markets Assumptions performed over time by asset class.
Private Markets

Significant Drops in Private Equity Activity From Peak Years of 2021-22

Ashley Kahn
Callan expert analyzes private equity activity in 1Q24, from fundraising to exits.
Private Markets

Sector-Specialist Strategies: What Institutional Investors Need to Know

Chrissy Mehnert
A look at sector-specialist strategies and how institutional investors can analyze them.
Private Markets

Private Equity Sees a Big Slowdown After Frenzy of 2021

Ashley Kahn
An update on private equity performance in 4Q23 and for the year.
Private Markets

ILS on Pace for Banner Year in 2023

Sean Lee
Sean Lee discusses the returns for insurance-linked securities (ILS) for the year-to-date.
Private Markets

Private Equity Investors Focus on Exits as Activity Drops

Alternatives Consulting Group
The Alternatives Consulting Group provides an update on private equity performance in 3Q23.
Operations

What Investors Need to Know About the SEC’s 2023 Private Funds Rules

Alternatives Consulting Group
The Alternatives Consulting Group analyzes the new SEC rules on unregistered private funds.

Callan Family Office

You are now leaving Callan LLC’s website and going to Callan Family Office’s website. Callan Family Office is not affiliated with Callan LLC.  Callan LLC has licensed the Callan® trademark to Callan Family Office for use in providing investment advisory services to ultra-high net worth clients, family foundations, and endowments. Callan Family Office and Callan LLC are independent, unaffiliated investment advisory firms separately registered with the Securities and Exchange Commission under the Investment Advisers Act of 1940.

Callan LLC is not responsible for the services and content on Callan Family Office’s website. Inclusion of this link does not constitute or imply an endorsement, sponsorship, or recommendation by Callan LLC of their website, or its contents, and Callan LLC is not responsible or liable for your use of it. When visiting their website, you are subject to Callan Family Office’s terms of use and privacy policies.